Invention Grant
- Patent Title: Phi29 DNA polymerase mutants having increased thermostability and processivity
-
Application No.: US15209992Application Date: 2016-07-14
-
Publication No.: US09885025B2Publication Date: 2018-02-06
- Inventor: Remigijus Skirgaila , Tadas Povilaitis
- Applicant: Thermo Fisher Scientific Baltics UAB
- Applicant Address: LT Vilnius
- Assignee: Thermo Fisher Scientific Baltics UAB
- Current Assignee: Thermo Fisher Scientific Baltics UAB
- Current Assignee Address: LT Vilnius
- Agency: McNeill Bauer PLLC
- Main IPC: C12N9/12
- IPC: C12N9/12 ; C12P19/34

Abstract:
Mutants of bacteriophage phi29 DNA polymerase with increased protein stability and increased half-life, compared to wild type DNA polymerase. The disclosed mutants are more stable in reaction mixtures with or without DNA. The inventive phi29 DNA polymerase mutants generate more amplification product. The inventive phi29 DNA polymerase mutants amplify genomic DNA with less bias compared to wild type DNA polymerase. Selected mutations increase the affinity of polymerase for DNA template.
Public/Granted literature
- US20170015980A1 PHI29 DNA POLYMERASE MUTANTS HAVING INCREASED THERMOSTABILITY AND PROCESSIVITY Public/Granted day:2017-01-19
Information query